Active Psoriatic arthritis Withdrawn Phase 4 Trials for Bimekizumab (DB12917)

Also known as: Psoriatic arthritis aggravated / Psoriatic arthropathy aggravated / Psoriatic arthropathy NOS (disorder) / Psoriatic arthropathy / Arthropathy psoriatic / Psoriatic arthritis / Psoriasis with arthropathy (disorder) / Arthritis, Psoriatic / Psoriatic arthropathies / Arthropathic psoriasis / Arthropathic psoriasis, unspecified

DBCOND0020384 (Active Psoriatic arthritis)Withdrawn4 IdentifierTitlePurposeDrugs
NCT05499416Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic ArthritisTreatment